Table 3.
Correlates of receiving each recommended adolescent vaccine (n = 647)
| Tetanus booster vaccinea | Meningococcal vaccineb | HPV vaccine | ||||
| n (%) | Multivariate OR (95% CI) | n (%) | Multivariate OR (95% CI) | n (%) | Multivariate OR (95% CI) | |
| Daughter Characteristics | ||||||
| Age (years) | ||||||
| 11–12 | 85 (80) | ref. | 34 (32) | 1.52 (0.88–2.63) | 25 (24) | ref. |
| 13–15 | 170 (88) | 1.87 (0.96–3.62) | 58 (30) | ref. | 75 (39) | 2.31 (1.32–4.04)** |
| 16–20 | 310 (89) | 2.00 (1.09–3.67)* | 142 (41) | 1.68 (1.13–2.50)* | 131 (38) | 2.04 (1.21–3.44)** |
| Health Insurance | ||||||
| None | 30 (88) | — | 8 (24) | — | 11 (32) | — |
| Public Only | 71 (88) | — | 28 (35) | — | 27 (33) | — |
| Private | 464 (87) | — | 198 (37) | — | 193 (36) | — |
| Had a Preventive Care Visit in Last Year | ||||||
| No | 81 (74) | ref. | 24 (22) | ref. | 9 (8) | ref. |
| Yes | 484 (90) | 2.94 (1.74–4.95)** | 210 (39) | 1.44 (0.86–2.43) | 222 (41) | 7.24 (3.55–14.78)** |
| Received Tetanus Booster Vaccinea | ||||||
| No | N/A | N/A | 14 (17) | ref. | 22 (27) | — |
| Yes | N/A | N/A | 220 (39) | 2.85 (1.53–5.33)** | 209 (37) | — |
| Received Meningococcal Vaccineb | ||||||
| No | 345 (84) | ref. | N/A | N/A | 115 (28) | ref. |
| Yes | 220 (94) | 2.66 (1.44–4.90)** | N/A | N/A | 116 (50) | 2.27 (1.60–3.23)** |
| Received One or More Doses of HPV Vaccine | ||||||
| No | 356 (86) | — | 118 (28) | ref. | N/A | N/A |
| Yes | 209 (90) | — | 116 (50) | 2.29 (1.60–3.27)** | N/A | N/A |
| Parent Characteristics | ||||||
| Age (years) | ||||||
| <40 | 121 (91) | — | 37 (28) | ref. | 45 (34) | — |
| 40+ | 444 (86) | — | 197 (38) | 1.55 (0.98–2.45) | 186 (36) | — |
| Sex | ||||||
| Female | 532 (87) | — | 224 (37) | — | 220 (36) | — |
| Male | 33 (87) | — | 10 (26) | — | 11 (29) | — |
| Race | ||||||
| Non-Hispanic White | 418 (87) | — | 167 (35) | — | 179 (37) | — |
| Non-Hispanic African American | 113 (86) | — | 49 (37) | — | 39 (30) | — |
| Other | 34 (92) | — | 18 (49) | — | 13 (35) | — |
| Education Level | ||||||
| High School or Less | 101 (83) | — | 30 (25) | ref. | 29 (24) | ref. |
| Some College or More | 464 (88) | — | 204 (39) | 1.59 (0.99–2.56) | 202 (38) | 1.69 (1.04–2.73)* |
| Household Characteristics | ||||||
| Income | ||||||
| <$60,000 | 225 (87) | — | 81 (31) | ref. | 84 (32) | — |
| $60,000+ | 317 (88) | — | 144 (40) | 1.27 (0.89–1.83) | 137 (38) | — |
| Not Reported | 23 (85) | — | 9 (33) | 1.03 (0.42–2.51) | 10 (37) | — |
| Urbanicity | ||||||
| Rural | 276 (86) | — | 109 (34) | — | 123 (38) | — |
| Urban | 289 (89) | — | 125 (38) | — | 108 (33) | — |
Note: Multivariate binary logistic models did not include variables with dashes (—). HPV, human papillomavirus; OR, odds ratio; CI, confidence interval, ref., referent group; N/A, not applicable.
a
Tetanus, diphtheria and acellular pertussis (Tdap) vaccine or tetanus and diphtheria toxoids (Td) vaccine.
b
Meningococcal conjugate vaccine (MCV4) or meningococcal polysaccharide vaccine (MPS V4).
*
p < 0.05,
**
p < 0.01.